EL7.AI
StocksMediumUpdated×2•Originally published 30 July 2026•Updated 30 July 2026•
2 min read

Labcorp Boosts Share Buyback by $1B and Raises Guidance After Strong Q2 Results

Key Facts

1Labcorp reported Q2 revenue of $3.73 billion, up 5.8% year-over-year, and raised its full-year 2026 guidance.
2TechnipFMC reported Q2 revenue of $2.76 billion, a 9% year-over-year increase, with net income reaching $362.7 million.

In a move reflecting strong confidence in its financial position, Labcorp announced Q2 2026 results featuring a $1.0 billion increase in its share repurchase authorization and a raise in full-year guidance. The company reported adjusted EPS of $4.99, exceeding analyst estimates driven by solid organic growth in specialty testing, while revenue reached $3.73 billion, a 5.8% year-over-year increase. According to reports, this performance was bolstered by biopharma laboratory services, although management noted a decline in free cash flow during the period.

These results coincide with positive performance from TechnipFMC in the energy sector, which posted revenue of $2.76 billion and 9% annual growth. Per market data, these figures demonstrate the ability of large-cap firms to expand operating margins, with Labcorp leveraging this momentum to invest in AI technologies as part of its long-term growth strategy. The buyback expansion signals a continued commitment to shareholder value despite the reported headwinds in cash flow generation.

Regarding price levels, LH stock stood at $314.23 and FTI closed at $72.39 (at close July 28, 2026). Investors should monitor technical support for LH at $314.23 and its recent low of $304.73 to gauge the sustainability of the post-earnings momentum. With no major catalysts in the upcoming economic calendar, traders will focus on the execution of the share buyback program and the impact of AI investments on operational efficiency in future quarters.